Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2, 3-dioxygenase activity in vitro.

Yu CJ, Zheng MF, Kuang CX, Huang WD, Yang Q.

J Alzheimers Dis. 2010;22(1):257-66. doi: 10.3233/JAD-2010-100684.

PMID:
20847417
2.

Use of Yokukansan (TJ-54) in the treatment of neurological disorders: a review.

de Caires S, Steenkamp V.

Phytother Res. 2010 Sep;24(9):1265-70. doi: 10.1002/ptr.3146. Review.

PMID:
20812276
3.

Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.

Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Sameshima T, Kawahara T, Goto I, Shudo K, Kurayama S, Nakamura J, Okahara K, Mitsuyama Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):541-5. doi: 10.1016/j.pnpbp.2010.02.016. Epub 2010 Feb 23.

PMID:
20184936
4.

Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.

Okahara K, Ishida Y, Hayashi Y, Inoue T, Tsuruta K, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Yoshida K, Noda S, Tomita S, Fujimoto M, Hosomi J, Mitsuyama Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):532-6. doi: 10.1016/j.pnpbp.2010.02.013. Epub 2010 Feb 17.

PMID:
20170698
5.

Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.

Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J.

Clin Neuropharmacol. 2009 Jan-Feb;32(1):6-9. doi: 10.1097/WNF.0b013e31817e08c3.

PMID:
19471183
6.

Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.

Monji A, Takita M, Samejima T, Takaishi T, Hashimoto K, Matsunaga H, Oda M, Sumida Y, Mizoguchi Y, Kato T, Horikawa H, Kanba S.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):308-11. doi: 10.1016/j.pnpbp.2008.12.008. Epub 2008 Dec 24.

PMID:
19138715
7.

Traditional Chinese medicine on four patients with Huntington's disease.

Satoh T, Takahashi T, Iwasaki K, Tago H, Seki T, Yaegashi N, Tobita M, Arai H.

Mov Disord. 2009 Feb 15;24(3):453-5. doi: 10.1002/mds.22447.

PMID:
19133663
8.

Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.

Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):761-4. doi: 10.1016/j.pnpbp.2007.12.003. Epub 2007 Dec 14.

PMID:
18201810
9.

Yi-gan san for the treatment of borderline personality disorder: an open-label study.

Miyaoka T, Furuya M, Yasuda H, Hayashia M, Inagaki T, Horiguchi J.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):150-4. Epub 2007 Aug 8.

PMID:
17765378
10.
11.

Preventive effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on the development of stress-induced acute gastric mucosal lesions in rats.

Ohta Y, Kobayashi T, Nishida K, Sasaki E, Ishiguro I.

J Ethnopharmacol. 1999 Nov 30;67(3):377-84.

PMID:
10617076

Supplemental Content

Support Center